Law on the control of drugs and precursors.

This Law regulates the organization, powers and tasks of the public authorities exercising control over the production, processing, trade, use, storage, import, export, transit, transportation and reporting of narcotic substances. The terms and rules here provided shall apply: for all plants and substances classified as intoxicating and psychotropic substances and preparations containing them; for all substances used in the production of narcotic and psychotropic substances classified as precursors. The text is divided into nine Chapters and a total of 110 articles. Titles of Chapters are as follows: (1) General; (2) National council on drug substances; (3) control bodies and interaction between them; (4) Prohibitions and limitations of plants, substances and preparations; (5) Control of drugs and medicinal products present on the drug list; (6) International cooperation; (7) Prevention of the use, treatment and psychosocial rehabilitation of persons with drug abuse situation; (8) Containment, confiscation and destruction of drugs and precursors; and (9) Forced administrative measures and administrative and penalty provisions.
This Law further sets out provisions regarding the: possible release of narcotic drugs into the market, import and export of substances classified as precursors or possible precursors; measures against the abuse and illicit trafficking in narcotic drugs; the measures for the implementation of the terms stipulated in the Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors, Council Regulation (EC) No 111/2005 of 22 December 2004 laying down rules for the monitoring of trade between the Community and third countries in drug precursors; and Commission Regulation (EC) No 1277/2005 of 27 July 2005 laying down implementing rules for Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and for Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third countries in drug precursors.